Indisulam was originally described as a potent antitumor agent that targeted the G1 phase of cell cycle via suppression of activation of CDK2 and cyclin E expression.1 More recently it has been found to act as a molecular glue promoting the recruitment o
* VAT and and shipping costs not included. Errors and price changes excepted
